30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Steve Rubin

Track

Insider profile

Currently holds positions in Bio-Reference Laboratories Inc, OPKO Health Inc, Non-Invasive Monitoring Systems Inc, Niagen Bioscience Inc and Red Violet Inc

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 87% 68% 82%
Transactions
15 93% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Bio-Reference Laboratories Inc Aug. 20, 2015 -
Executive Vice President - Administration, Director OPKO Health Inc May 4, 2007 -
Independent Director Non-Invasive Monitoring Systems Inc Oct. 30, 2008 -
Independent Director Niagen Bioscience Inc March 27, 2017 -
Independent Director Red Violet Inc March 1, 2018 -
Independent Director Fluent Inc Oct. 30, 2009 - March 12, 2018
Interim Chief Executive Officer, Interim Chief Financial Officer, Director BioCardia Inc May 10, 2016 - Oct. 24, 2016
Independent Director BioCardia Inc Sept. 19, 2008 - May 10, 2016
Independent Director Transenterix Inc Sept. 4, 2007 - Sept. 3, 2013
Steve Rubin's trades of Entera Bio Ltd's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-17 2026-02-12
B Purchase
76,116 -42.3%
415.64
US$3,253,532 		76,116 -42.3% 415.64 US$3,253,532
2026-02-11 2026-02-09
B Purchase
86,981 +27.6%
415.92
US$4,206,969 		86,981 +27.6% 415.92 US$4,206,969
2025-03-21 2025-03-19
S Sale
8,144 +49.1%
464.32
US$2,910,125 		8,144 +49.1% 464.32 US$2,910,125
2025-03-19 2025-03-19
PrS Proposed sale
10,000
38.93
US$389,307 		10,000 38.93 US$389,307
2024-01-05 2024-01-05
B Purchase
10,000 +0.2%
0.87
US$8,669 		10,000 +0.2% 0.87 US$8,669
2023-11-13 2023-11-10
B Purchase
10,000 +0.2%
1.30
US$13,000 		10,000 +0.2% 1.30 US$13,000
2023-05-30 2023-05-25
B Purchase
7,000 +inf%
1.46
US$10,220 		7,000 +inf% 1.46 US$10,220
2020-08-27 2020-08-26
B Purchase
2,500 +0.0%
4.01
US$10,025 		2,500 +0.0% 4.01 US$10,025
2020-08-27 2020-08-26
B Purchase
2,500 +0.0%
3.99
US$9,968 		2,500 +0.0% 3.99 US$9,968
2020-08-27 2020-08-26
B Purchase
5,000 +0.1%
3.99
US$19,950 		5,000 +0.1% 3.99 US$19,950
2019-10-25 2019-10-25
B Purchase
15,000 +0.3%
1.50
US$22,500 		15,000 +0.3% 1.50 US$22,500
2019-05-10 2019-05-09
B Purchase
7,200 +0.1%
2.15
US$15,480 		7,200 +0.1% 2.15 US$15,480
2019-05-10 2019-05-09
B Purchase
2,600 +0.0%
2.13
US$5,538 		2,600 +0.0% 2.13 US$5,538
2019-05-10 2019-05-09
B Purchase
200 +0.0%
2.12
US$424 		200 +0.0% 2.12 US$424
2019-03-07 2019-03-06
B Purchase
2,435 +0.0%
2.56
US$6,234 		2,435 +0.0% 2.56 US$6,234
2019-03-07 2019-03-06
B Purchase
5,565 +0.1%
2.56
US$14,219 		5,565 +0.1% 2.56 US$14,219